NEW YORK, Aug. 14, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of FutureFuel Corp. (NYSE: FF) between August 10, 2023 and May 10, 2024, both dates inclusive (the "Class Period"), of the important August 23, 2024 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased FutureFuel Corp. securities during the Class Period you may be entitled to compensation without payment of any out of pocket ...

NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) between October 12, 2023 and June 26, 2024, both dates inclusive (the "Class Period"), of the important September 10, 2024 lead plaintiff deadline. SO WHAT: If you purchased Walgreens securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee ...

NEW YORK, Aug. 12, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Seritage Growth Properties (NYSE: SRG) between July 7, 2022 and May 10, 2024, both dates inclusive (the "Class Period"), of the important August 30, 2024 lead plaintiff deadline. SO WHAT: If you purchased Seritage securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. W ...

NEW YORK, Aug. 10, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of lululemon athletica inc. (NASDAQ: LULU) between December 7, 2023 and July 24, 2024, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 7, 2024. SO WHAT: If you purchased lululemon securities during t ...

财务数据和关键指标变化 - 2024年第二季度总收入为3600万美元,同比增长5% [13] - 软件收入为2930万美元,同比增长8% [13] - 服务收入为670万美元,同比下降7% [55] - 调整后EBITDA为负470万美元,调整后EBITDA利润率为负13% [60] - 现金和现金等价物为1.3亿美元,无债务 [62] 各条业务线数据和关键指标变化 - 软件收入占总收入的81%,同比增长8% [55] - 服务收入占总收入的19%,同比下降7% [55] 各个市场数据和关键指标变化 - 公司目前有1449名客户 [14] - 前300大客户贡献了75%的收入,主要为大型律所和企业客户 [68][69] 公司战略和发展方向及行业竞争 - 公司将重点关注客户关注、运营效率和文化改善,以加速收入增长 [21][22][35] - 加强销售团队建设,引进更多有丰富企业级销售经验的人才 [26][27] - 推出基于自然语言处理的Cecilia Q&A和Cecilia Auto Review产品,提升客户体验和工作效率 [39][45] - 持续完善Ediscovery核心产品,推出大规模自动化编辑功能 [51] - 行业内普遍看好人工智能技术在法律服务中的应用前景 [82][83] 管理层对经营环境和未来前景的评论 - 公司在产品、服务和客户关系方面已经取得了很大进步,但仍需进一步提升运营效率和公司文化 [16][35][36] - 公司看好未来发展前景,将继续投资人才引进和业务流程优化,但不会在2024年大幅改变调整后EBITDA [37] - 客户普遍对公司产品和服务表示满意,希望进一步扩大使用 [18][19][20] 其他重要信息 - 公司任命Richard Crum为新任首席产品官,负责产品团队建设和跨职能协作 [31][32] - 公司正在完善内部流程和系统,提升销售、客户体验和业务决策效率 [33][34] 问答环节重要的提问和回答 问题1 **Brian Essex 提问** 询问大型客户占比及其增长情况 [66][67] **Eric Friedrichsen 回答** 大型客户(主要为大型律所和企业)贡献了75%的收入,是公司重点关注的客户群体,未来将更多关注扩大在这些客户中的渗透率 [68][69][70][72] 问题2 **Mark Schappel 提问** 询问引进新的产品负责人的原因 [74] **Eric Friedrichsen 回答** 引进Richard Crum作为新任首席产品官,是为了进一步提升产品团队的客户导向和商业意识,推动跨职能协作 [76] 问题3 **Luv Sodha 提问** 询问公司对未来业绩的信心及指引保守性 [84][85][88] **Michael Lafair 回答** 公司对未来发展前景保持乐观,但在给出指引时仍采取谨慎态度,未来会根据实际情况适当调整 [88]

NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Toyota Motor Corporation (NYSE: TM) between June 23, 2022 and June 2, 2024, both dates inclusive (the "Class Period"), of the important August 23, 2024 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Toyota securities during the Class Period you may be entitled to compensation without payment of any out of pocket fee ...

NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lifecore Biomedical, Inc. (NASDAQ: LFCR) between October 7, 2020 and March 19, 2024, both dates inclusive (the "Class Period"), of the important September 27, 2024 lead plaintiff deadline. SO WHAT: If you purchased Lifecore securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arra ...

NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) between February 5, 2021 and May 14, 2024, both dates inclusive (the "Class Period"), of the important September 3, 2024 lead plaintiff deadline. SO WHAT: If you purchased Bolt securities durig the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangemen ...

CS Disco (LAW) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.11 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 22.22%. A quarter ago, it was expected that this legal technology company would post a loss of $0.12 per share when it actually produced a loss of $0.08, delivering a surprise of 33.33%. Over the last four quarters, the company h ...

公司概况 - 公司提供云原生、人工智能驱动的法律产品,简化法律保留、法律请求、电子发现、法律文件审查和案件管理[136] - 公司客户包括各行业的企业、律所、法律服务提供商和政府机构,销售主要通过直销团队[139,140] 收入情况 - 公司收入主要来自客户使用产品的实际使用量,客户可选择年度或多年期的最低使用量订阅[137] - 客户使用公司产品后,可增加使用量以覆盖更多法律事务,提高产品的战略价值和粘性[138] - 总收入同比增长5%，达到3.6005亿美元[172] - 软件产品收入增长8%，服务产品收入下降7%[174,175] - 总收入同比增长6%，达到7.1576亿美元[187,188] - 软件产品收入增长8%，服务产品收入下降3%[189] 成本费用 - 研发费用同比下降3%，主要由于人员成本和重组费用的减少[179,180] - 销售和营销费用同比下降14%，主要由于人员成本和重组费用的减少[181,182] - 一般管理费用同比下降2%，主要由于人员成本的减少[184,185] - 成本of revenue同比增长5%，主要由于云服务成本和人工成本的增加[191,192] - 研发费用同比下降14%，主要由于人员成本和重组费用的减少[193][194][195] - 销售和营销费用同比下降16%，主要由于销售人员人员成本和差旅费的减少[196][197] - 管理费用同比下降6%，主要由于人员成本和保险费用的减少[198][199] 财务状况 - 公司于2024年6月30日拥有1.3亿美元的现金和现金等价物[141] - 公司调整后EBITDA为负470万美元[143] - 公司现金和现金等价物为1.3亿美元，预计未来12个月内现金可以满足需求[204][205][206][207][208] - 经营活动现金流出同比下降63%，主要由于净亏损减少和应收账款回款增加[210][211][212] - 投资活动现金流出同比下降63%，主要由于收购支出减少和资本支出减少[213] - 融资活动现金流出同比增加1848%，主要由于股票回购支出增加[214] 其他 - 宏观经济不确定性可能对公司业务产生负面影响[144,145] - 公司调整了Adjusted EBITDA的计算方式，剔除了一些非经常性费用[200][201][202][203] - 公司采用公允价值确认的股票激励政策，根据授予日的公允价值确认为费用，并在服务期内摊销[218] - 公司CEO绩效股票期权的授予及后续注销情况[219][220][221] - 公司在并购时会根据被收购资产和负债的公允价值进行分配，并确认商誉，需要做出重大估计和假设[222] - 公司作为新兴成长公司可以享受JOBS法案的相关豁免政策[224] - 公司面临利率风险和汇率风险，但目前影响较小[225][226][227]